20/07/2015
INDEX
OPEN
HIGH
LOW
CLOSE
CNX NIFTY
8401
8652
8360
8625
BANK NIFTY
18822
19280
18701
19148
INDEX
R2
R1
PP
S1
S2
CNX NIFTY
8837
8731
8545
8439
8253
BANK NIFTY
19622
19385
19043
18806
18464
OPEN INTEREST AND VOLUME
INDEX
CURRENT
PREVIOUS % CHANGE
NIFTY OI
102478825
90713175
12.97%
NIFTY VOLUME
1928907
2643276
-27.05%
BANK NIFTY OI
8943975
8603875
3.95%
569550
674921
-15.1%
BANK NIFTY VOLUME
FII AND DII WEEKLY TRADING
FII TRADING (RS. IN CRORE) FII
ACTIVITY GROSS
PURCHASE
GROSS SALES
NET
PURCHASE/SALES
17 July 2015
3347.75
2742.19
605.56
16 July 2015
3250.41
2504.60
745.81
15 July 2015
3292.92
2885.23
407.69
14 July 2015
3148.88
2878.98
269.90
13 July 2015
3477.95
2949.97
527.98
Weekly Position
2556.94
DII TRADING (RS. IN CRORE) DII
GROSS PURCHASE
GROSS SALES
NET
PURCHASE/SALES
17 July 2015
1331.99
1507.14
-175.15
16 July 2015
1632.69
1731.20
-98.51
15 July 2015
1384.34
1434.72
-50.38
14 June 2015
1227.27
1358.17
-130.90
13 July 2015
1081.26
1252.81
-171.55
Weekly Position
-626.49
0.000
FII and DII Statistics provides one with information about the quantity and price of the various instruments bought and sold by the Foreign Institutional Investors (FII) and Domestic Institutional Investors during the day in the Derivative Market.
Indian indices continue bullish during the last week rally and closed on positive note amid market up Indian Indices jump above support levels on the last trading day of June series F&O expiry. On sectorial front Banking, Metals, Infra, Financials sectors were up as well as Pharma and IT sectors remained stable and up during the week. Week ahead, market is likely to trend upside heading towards 8600 level as nifty has follow in channel weekly and weekly charts that signals further buy in market. Nifty given closing at positive in weekly chart by open 8401 level to settle at 8625 on the above chart Nifty has been trading in over all uptrend, following a channel formation above 8410 with the technical and fundamental supports for upside. Nifty was strong support level at 8000, nifty don’t broken the level 8000. Now channel has been completed with the high on 8445. Nifty has brooked the level 8350 then it could touch the level of 8700/8900 for long term. Nifty, in last week trading session it was up closed at 8625. Its long term trend is up. On weekly chart it has given breakout at above 8488 in channel. Stochastic and RSI has also buying confirmation. On weekly chart nifty has given breakout level at above 8350. We have recommended buy nifty future from current market Price 8625 hold for target is 8700, in coming weeks.
CEAT LTD TECHNICAL VIEW
Stock Recommendation for 20/07/2015 is CEAT LTD. In Friday’s trading session it was up 2.18 %. Its long term trend is up. RSI and Parabolic SAR also indicate buying confirmation. So our buying level is above 750 and our target is 775 and 800 in coming days. Our stop loss 725 is the entire indicator is suggesting that one can go for long position in the stock at above 750 levels. Our recommendation CEAT LTD buy above 750 for 1st target 775 and 2nd Target 800 with stop loss level 725.
SKS Micro Finance Limited TECHNICAL VIEW
Stock Recommendation for 20/07/2015 is SKS Micro Finance Limited. In Friday’s trading session it was up 1.81%. Its long term trend is up. In weekly & daily chart its trend is bullish. So our buying level is above 525 and our target is 550 and 575 in coming days. Our stop loss is 500 the entire indicator is suggesting that one can go for long position in the stock at above 525 levels. Our Recommendation on SKSMICRO buy above 525 for 1st target 550 and 2nd Target 575 with stop loss level 500.
PAST PERFORMANCE OF STOCK RECOMMENDATION DATE
SCRIPT
ORDER
COST LEVEL
1 ST TGT
2 ND TGT
SL
29 June
EICHERMOT
Buy
19738
20138
20538
-
29 June
BAJFINANCE
Buy
5410
5530
-
-
22 June 08 June MARUTI Coal India
Buy Buy
3960 408
15 June
ONGC
Sell
300
01 25 May Voltas 08June June BPCL IOB
Buy Buy Sell
857.50 317 38
4080-
--
- 398
-
-
315
869.50 321 37
- 36 325
--
Lupin rises 1% on USFDA approval for diabetes drug Lupin gets approval from US Food and Drug Administration for diabetes drug. The pharma major has received an approval from the USFDA for PrandiMet (also known as Prandin) generic that is used for treatment of type 2 diabetes. Danish pharmaceutical company Novo Nordisk is the innovator of the drug and has received approval from USFDA in June 2008. "PrandiMet had been approved to lower the blood glucose in adult patients with type 2 diabetes whose hyperglycemias cannot be controlled satisfactorily by meglitinide and/or metformin," Novo said in its release published in 2008. Analysts feel this could be a limited competition drug. Actavis and Sandoz are few of the other generic filers for Prandin. ACC Q2 profit seen down 11%, volumes may decline Cement major ACC is expected to de grow in the quarter ended June. Profit is likely to fall 11 percent year-on-year to Rs 217 crore and total income may drop 2 percent to Rs 3,012 crore. The company follows January-December as its financial year. Analysts expect cement volumes to decline in April-June quarter (following weakness in past two consecutive quarters) due to poor sales seen in Southern and Northern markets. The top line of ACC, which has pan India presence, may be dragged by lower volumes but realisations and RMC may support. Analysts see poor realisations in northern and western regions. Motherson Sumi at record high on strong European car sales Shares of Motherson Sumi Systems touched a life high of Rs 539.45 on Friday, up 3 percent intraday after European car sales hit highest level since 2009. The stock rallied 18 percent in the current calendar year 2015. European subsidiaries contribute about 80 percent to the total revenues of Motherson. According to data published by the European Automobile Manufacturers Association on July 16, Europe's car registration showed 15 percent growth in June despite Greece crisis, the biggest year-on-year rise in monthly car sales since December 2009. During January-June period of 2015, new registrations for passenger cars in Europe rose by 8.2 percent to more than 7 million units.
5 sectors affected by the Union Budget 2015. The finance minister presents his budget in 2 parts: Board policy and Tax proposals Board policy initiatives indicate the stance of the budget. If the budget is allocating resources for spending on infrastructure, a lot of related business is affected. Tax proposals: when tax rates or duties are changed, they affected individuals or companies accordingly. The ability of this company to pass on changes in tax rates to customers determines their future profitability. The sector here is some sector that has been impacted. 1 power: Power production required fuel. Any changes in tax on fuel could make or break a project. 2 Real Estate: Low cost housing and urbanization influences the real estate sector. The budget is watched very closely fir incentives offered towards this. 3 Infrastructures: this is perhaps the most affected sector in the budget. The government spending on rural and urban infrastructures leads to a significant business for companies that build it. 4 Automobiles: Excise duty on manufacturing on cars in India changes in every other budget while the duty on vehicles with smaller engines is less; it is more on vehicles that have a powerful engine. 5 Oil and Gas: Petroleum subsidies keep prices of diesels, kerosene or LPG low. Since fuel prices to retail customers and profitability of companies are determined by the amount of subsidies, investors listen to the finance minister’s budget speech for a stance on fuel pricing going ahead.
The information contained here was gathered from sources deemed reliable however; no claim is made as to accuracy or content. This does not contain specific recommendations to buy or sell at particular prices or time, nor should any examples presented be deemed as such. There is a risk of loss in equity trading and you should carefully consider your financial position before making a trade. This is not, nor is it intended, to be a complete study of chart patterns or technical analysis and should not be deemed as such. Money Classic Investment Advisors does not guarantee that such information is accurate or complete and it should not be relied upon as such. Any opinions expressed reflect judgments at this date and are subject to change without notice. For use at the sole discretion of the investor without any liability on Money Classic Investment Advisors. • MONEY CLASSIC INVESTMENT ADVISORS • WEBSITE- WWW.MONEYCLASSIC RESEARCH.COM • EMAIL- INFO@MONEYCLASSICRESEARCH.COM • CONTACT NO. - (M) 9039777700, (0)0731-4094475